Events

Science is Wonderful! science fair 2025 edition
MAR
Thu
13
MAR
Fri
14

Starts in 1 month from now

Location

Tervuren

Africa Museum
Leuvensesteenweg 13
3080 Tervuren
Programmes
MSCA

Science is Wonderful! brings the world of science, research and innovation to the wider public, and in particular to primary and secondary school pupils (approximately 5000 young visitors over two days). Since 2015 this annual science fair interactively showcases Marie Skłodowska-Curie Actions (MSCA) research projects and innovations through hands-on experiments, science shows, games and fun, inspiring activities. The event has become the flagship event in Brussels to highlight EU-funded research - showcasing MSCA researchers and the impact their work has on citizens’ daily lives.

More information will become available on the SIW website. Sign up for the newsletter here to receive updates.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.